Science & ResearchAug 26, 2026
Recombinant shingles vaccination and the risk of cardiovascular events.
The recombinant herpes zoster (shingles) vaccine may reduce risks of cardiovascular disease.
The recombinant herpes zoster (shingles) vaccine may reduce risks of cardiovascular disease. However, existing studies have compared vaccine recipients with non-recipients and, thus, are susceptible to confounding. To mitigate these biases, we conducted a natural experiment…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.